Orally administered epeleuton inhibits SARS-CoV-2 viral load, replication and pathology in the Syrian Hamster model
J. Climax, M. Hamza, A. Lafferty, K. Guilfoyle, G. van Amerongen, K. Stadler, P. Wohlsein, W. Baumgärtner, M. Weissbach, D. Coughlan
This study shows that epeleuton reduces SARS-CoV-2 viral load, replication, and lung pathology in Syrian hamsters when administered orally.
bioRxiv · Dec 7, 2021 · PreprintMicrobiology